N-Oleoylethanolamine (OEA, Oleamide MEA)
bioactive lipid mediator with several potential health benefits, particularly related to obesity, inflammation, and oxidative stress
Oleoylethanolamide (OEA, Oleamide MEA) is a bioactive lipid mediator with several potential health benefits, particularly related to obesity, inflammation, and oxidative stress. The following are the key health benefits of OEA based on the provided sources:
Anti-inflammatory and Antioxidant Effects
- OEA supplementation has been shown to reduce inflammation in obese individuals by significantly decreasing serum concentrations of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [1].
- It also has antioxidant properties, which may help reduce oxidative stress, although changes in malondialdehyde (MDA), total antioxidant status (TAS), and high sensitive-C reactive protein (hs-CRP) were not significant in the study[1].
Weight Management and Satiety
- OEA is known to induce a feeling of satiety after meals, which can aid in weight management[3].
- It has been observed to reduce appetite and body weight in obese individuals through the activation of the nuclear receptor PPAR-alpha[2][5].
- In animal studies, both injections and oral intake of OEA caused a reliable reduction in the amount of food eaten[3].
Effects on Gut Microbiota and Intestinal Health
- OEA treatment can affect gut microbiota composition and enhance the expression of intestinal cytokines in Peyer’s patches, which are important for protective mucosal immune responses[4].
- It may also contribute to a less inflammatory milieu in the gut[4].
Potential for Treating Metabolic Disorders
- OEA has been proposed as a candidate for the treatment of non-alcoholic fatty liver disease due to its PPAR-alpha activation properties[2].
Pain Management
- Among women with dysmenorrhea (painful menstruation), supplementing with OEA reduced pain severity and improved markers of inflammation[3].
Potential Neurological and Psychological Benefits
- OEA may help control depression through hormonal and neurological patterns, as observed in animal studies[5].
- It has been shown to reduce unpredictable mild stress in animal models[5].
Hormonal Balance
- OEA supplementation may regulate hormonal balance and neurotransmitter production in the brain[5].
Appetite Regulation
- OEA reduces the levels of appetite-stimulating hormones like peptide YY (PYY), which can lead to enhanced satiety and potentially support fat-burn enhancement[5].
Citations:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156479/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119414/
[3] https://examine.com/supplements/oleoylethanolamide/
[4] https://www.nature.com/articles/s41598-018-32925-x
[5] https://www.nutriavenue.com/n-oleoylethanolamide-a-must-have-compound-in-weight-loss-2/
- Room (25-40C)
- 24 Months from manufacturing or testing date.
- 100mg - 200mg
- 150mg
- 100mg - 200mg
- 150mg
- Add into oil phase. May heat 70-80C to increase solubility
- Avoid heat above 80C
- 3.50 - 7.00
- Soluble in Oil, Dispersible in cream or gel base, Soluble in DMSO (Dimethyl Sulfoxide)
- -
| Test Name | Specification |
|---|---|
| Appearance | White to off-white powder |
| ID | The retention time of the major peak of test solution should correspond to that of the standard spectrum |
| Purity (HPLC) | Min 92.0% |
| Loss on drying | Max 2.0% |
| Residue on ignition | Max 0.5% |
| Heavy metal | Max 20 ppm |
| Cadmium | Max 5 ppm |
| Lead | Max 10 ppm |
| Mercury | Max 1 ppm |
| Arsenic | Max 2 ppm |
| Aerobic Bacteria Count | Max 100 cfu/g |
| Yeasts & Molds | Max 10 cfu/g |
| Fungus Count | Max 100 cfu/g |
Cart
No products